Friday, August 18, 2017 6:08:07 PM
If Nantcell is in on it they are foolish,
If anything, since the product/s is/are real and the global license deal is evident both companies should merge an a profitable agreement reached without share splits.
Paper holds every word you put on it,
An RS is like cheating, the company will not be trusted again.
RS "NO"
6 month daily chart, forth run of the year coming up. Hold your shares.
http://www.fiercebiotech.com/biotech/soon-shiong-s-nantcell-356m-deal-for-underperforming-cytrx-cancer-drug
Mr Soon is beru smart and has a ton of money, they will be loading up next week,
This is a strategic plan to acquire cheap shares.
Wise
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM